YOKNEAM, Israel, Aug. 1, 2024/ PRNewswire/-- InMode Ltd., a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended ...

(1) Tax benefit recorded during the year ended December 31, 2024, as a result of a release of valuation allowance on our deferred tax assets in the United States as it is more likely than not that our ...

With Ignite, physicians may adjust the depth of the power, allowing for more effective treatment in less time. These features are highly valued by physicians that aspire to shorten treatment time ...

Shares of InMode (NASDAQ: INMD), a medical technology company focused on the aesthetics industry, recently reached a new 52-week high in anticipation of the second-quarter earnings report the company ...

Gross margins decline — Yair Malca stated, "GAAP and non-GAAP gross margins in Q3 were 78%, down from 82% reported in Q3 2024," citing the anticipated impact of tariffs as a direct driver. Reduced ...

Joseph Stringer: Okay. Great. Yes. Thanks for all that color. I guess maybe just moving on to the new platform. So, you are launching some upgraded platforms to your legacy. Your legacy devices, I ...

Good day, and welcome to InMode's second quarter 2024 earnings results conference call. All participants will be in listen-only mode. [Operator instructions]. After today's presentation, there will be ...